Opportunity Information: Apply for CDC RFA PS10 1087
Apply for CDC RFA PS10 1087
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Implementation of Prevention, Care, and Treatment Programs for Individuals with HIV/AIDS in the Central Asian Republics of Kazakhstan, Kyrgyz Republic, Tajikistan, Turkmenistan and Uzbekistan under the Presidents Emergency Plan for AIDS Relief (PEPFA" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Apr 26, 2010 and posted on Mar 16, 2010.
- Applicants must submit their applications by May 17, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $5,000,000.00 to eligible and selected applicants.
- The number of recipients for this funding is limited to 4 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity, issued by the Centers for Disease Control and Prevention (CDC) under the President's Emergency Plan for AIDS Relief (PEPFAR), focuses on scaling up HIV prevention, care, and treatment services across five Central Asian countries: Kazakhstan, the Kyrgyz Republic, Tajikistan, Turkmenistan, and Uzbekistan. Structured as a cooperative agreement, the program is designed for situations where CDC expects to have substantial involvement with recipients during implementation, which typically means funded organizations are not only delivering services but also coordinating closely with CDC on planning, monitoring, and technical approaches.
The core purpose of the announcement is to expand HIV services in the targeted Central Asian Republics. In practical terms, this generally points to strengthening and widening the availability and quality of HIV-related interventions, including prevention programming (such as risk reduction efforts and outreach to populations with elevated vulnerability), improved access to HIV testing and linkage to care, and stronger clinical care and treatment systems for people living with HIV. Because the activity category is listed as Health and the CFDA number is 93.067 (Global AIDS), the opportunity sits within the broader U.S. government global HIV response framework and is meant to support country and regional efforts to reduce HIV transmission while improving health outcomes for individuals affected by HIV/AIDS.
Funding for the opportunity was projected at approximately 1,000,000 dollars in fiscal year 2010 to support four awards, indicating an intent to fund multiple implementers or partners rather than a single large project. In the full source data, the estimated total funding is listed as 5,000,000 dollars, which suggests the broader anticipated funding across the entire project period or across awards rather than only the first-year allocation. Notably, the listing shows no cost sharing or matching requirement, which means applicants were not expected to contribute a mandatory non-federal share as a condition of receiving an award, lowering a common barrier to entry for nonprofits, academic institutions, and other implementers.
Key timing details are clearly laid out. The opportunity was posted on March 16, 2010, and applications were due by May 17, 2010, with the archive date of June 16, 2010 indicating when the posting would have been removed from active listings. The anticipated project period was scheduled to begin on September 30, 2010 and run through September 30, 2013, establishing a roughly three-year implementation window. The award ceiling and floor are both listed as 0 in the source fields, which typically means the announcement did not specify fixed minimum or maximum award sizes in those particular data fields and applicants needed to consult the full announcement text on Grants.gov for more precise budget guidance and expectations.
Eligibility is described as unrestricted, meaning the competition was broadly open to many entity types, subject to any additional eligibility clarifications contained in the full funding opportunity text. This kind of open eligibility often attracts a mix of applicants, including non-governmental organizations, universities, international organizations, and potentially private entities, provided they can meet U.S. federal grant requirements and demonstrate the technical capacity to deliver HIV programming in the specified countries.
Administratively, the opportunity is identified by Funding Opportunity Number CDC RFA PS10-1087 and is managed through CDC's Procurement and Grants Office. Applicants needing help accessing the full announcement were directed to CDC PGO's Technical and Information Management Section (TIMS) at 770-488-2700, with a general email contact also referenced. The announcement itself points applicants to Grants.gov for complete program details, implying that the full document would contain the specific program strategies encouraged or required, detailed application instructions, evaluation criteria, reporting and performance measurement expectations, and the cooperative agreement terms describing how CDC would engage with awardees during the project.
Frequently Asked Questions (FAQs)
What is this funding opportunity about?
This Centers for Disease Control and Prevention (CDC) funding opportunity under the President's Emergency Plan for AIDS Relief (PEPFAR) focuses on scaling up HIV prevention, care, and treatment services in Central Asia. The overall intent is to expand HIV services and strengthen the availability and quality of interventions that reduce HIV transmission and improve outcomes for people affected by HIV/AIDS.
Which countries are included in the program area?
The opportunity targets five Central Asian countries: Kazakhstan, the Kyrgyz Republic, Tajikistan, Turkmenistan, and Uzbekistan.
What type of award is this?
This opportunity is structured as a cooperative agreement. That generally means CDC expects to have substantial involvement with recipients during implementation, such as collaborating on planning, monitoring, and technical approaches while the recipient carries out program activities.
What kinds of activities does the opportunity support?
Based on the description provided, the opportunity supports expanding and strengthening HIV services across prevention, testing, linkage to care, and treatment systems. Examples mentioned include prevention programming such as risk reduction efforts and outreach to populations with elevated vulnerability, improved access to HIV testing and linkage to care, and stronger clinical care and treatment systems for people living with HIV.
How does this opportunity fit within broader U.S. government HIV programming?
The activity category is listed as Health and the CFDA number is 93.067 (Global AIDS). This places the opportunity within the broader U.S. government global HIV response framework, supporting country and regional efforts to reduce HIV transmission and improve health outcomes.
What is the Funding Opportunity Number?
The Funding Opportunity Number is CDC RFA PS10-1087.
Who is the administering agency and office?
The opportunity is issued by the Centers for Disease Control and Prevention (CDC) and managed through CDC's Procurement and Grants Office.
How much funding was expected to be available?
The description notes approximately $1,000,000 projected in fiscal year 2010 to support four awards. It also notes an estimated total funding amount of $5,000,000 in the full source data, which suggests broader anticipated funding across the project period and/or across awards rather than only the first-year allocation.
How many awards were anticipated?
The opportunity indicated an intent to support four awards.
Is cost sharing or matching required?
No. The listing shows no cost sharing or matching requirement, meaning applicants were not expected to provide a mandatory non-federal share as a condition of receiving an award.
Were minimum or maximum award sizes specified?
The award ceiling and floor are both listed as 0 in the source fields. This typically indicates that specific minimum or maximum award sizes were not stated in those particular data fields, and applicants would need to consult the full announcement on Grants.gov for precise budget guidance and expectations.
Who was eligible to apply?
Eligibility is described as unrestricted, meaning the competition was broadly open to many entity types, subject to any additional eligibility clarifications in the full funding opportunity text.
What types of organizations might this opportunity attract?
Because eligibility is described as unrestricted, the opportunity may attract a range of applicants such as non-governmental organizations, universities, international organizations, and potentially private entities, as long as they can meet U.S. federal grant requirements and demonstrate technical capacity to deliver HIV programming in the specified countries.
When was the opportunity posted?
The opportunity was posted on March 16, 2010.
What was the application due date?
Applications were due by May 17, 2010.
What does the archive date mean, and what was it for this opportunity?
The archive date generally indicates when the posting would have been removed from active listings. For this opportunity, the archive date was June 16, 2010.
What was the anticipated project period?
The anticipated project period was scheduled to begin on September 30, 2010 and run through September 30, 2013, which is roughly a three-year implementation window.
Where were applicants expected to find the full program details and instructions?
The announcement points applicants to Grants.gov for complete program details. The full posting would typically include program strategies, application instructions, evaluation criteria, reporting and performance measurement expectations, and cooperative agreement terms describing CDC involvement.
What kind of involvement should recipients expect from CDC under a cooperative agreement?
The description states that CDC expects substantial involvement with recipients during implementation. This typically includes close coordination with CDC on planning, monitoring, and technical approaches while the recipient carries out program activities.
Who could applicants contact for help accessing the announcement?
Applicants needing help accessing the full announcement were directed to CDC PGO's Technical and Information Management Section (TIMS) at 770-488-2700. A general email contact was also referenced in the announcement materials.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: WaterSMART Water and Energy Efficiency Grants for FY2010
Previous opportunity: National Center for Chronic Disease Prevention and Health Promotion, Division of Cancer Prevention and Control
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA PS10 1087
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA PS10 1087) also looked into and applied for these:
| Funding Opportunity |
|---|
| Strengthening Pre Service and In Service Training in the Context of Health System Strengthening in Central Asian Republics of Kazakhstan, Kyrgyz Republic, Tajikistan, Turkmenistan, and Uzbekistan Under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS10 1088 Funding Number: CDC RFA PS10 1088 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $4,000,000 |
| Prevention of HIV Transmission through Strengthening Blood Safety in the Republic of Zimbabwe under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10149 Funding Number: CDC RFA PS10 10149 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,800,000 |
| Technical Assistance to Strengthen Blood Safety of the Ministry of Health in the Central Asian Republics of Kazakhstan, Kyrgyz Republic, Tajikistan, Turkmenistan, and Uzbekistan Under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10104 Funding Number: CDC RFA PS10 10104 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| HIV/AIDS Program Implementation Support Through Local Universities in the Federal Democratic Republic of Ethiopia Under The Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10114 Funding Number: CDC RFA PS10 10114 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $100,000 |
| AIDS Education and Training Center (AETC) National Center for Expansion of HIV Care in Minority Communities Building Capacity in Community Health Centers Apply for HRSA 10 121 Funding Number: HRSA 10 121 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| The Role of Cellular Organelles in Alcohol Induced Tissue Injury (R01) Apply for PA 10 085 Funding Number: PA 10 085 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| The Role of Cellular Organelles in Alcohol Induced Tissue Injury (R21) Apply for PA 10 086 Funding Number: PA 10 086 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Stress Pathways in Alcohol Induced Organ Injury and Protection (R21) Apply for PA 10 094 Funding Number: PA 10 094 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Stress Pathways in Alcohol Induced Organ Injury and Protection (R01) Apply for PA 10 093 Funding Number: PA 10 093 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Alcohol Use Disorders Treatment, Services Research, and Recovery (R01) Apply for PA 10 100 Funding Number: PA 10 100 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Alcohol Use Disorders Treatment, Services Research, and Recovery (R21) Apply for PA 10 102 Funding Number: PA 10 102 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Alcohol Use Disorders Treatment, Services Research, and Recovery (R03) Apply for PA 10 101 Funding Number: PA 10 101 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Secondary Analyses of Social and Behavioral Datasets in Aging (R03) Apply for PA 10 139 Funding Number: PA 10 139 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Technical Assistance to Behavior Change Communication (BCC) on Comprehensive Peer Education Program and the National AIDS Resource Center (NARC) Programs under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10116 Funding Number: CDC RFA PS10 10116 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $3,000,000 |
| Ancillary Studies in Clinical Trials (R01) Apply for RFA HL 10 024 Funding Number: RFA HL 10 024 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Hepatitis C Treatment Expansion Initiative Evaluation and Technical Assistance Center Apply for HRSA 10 216 Funding Number: HRSA 10 216 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Division of Diabetes Translation Earmarks 2010 Apply for CDC RFA DP10 1004E Funding Number: CDC RFA DP10 1004E Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Transforming Biomedicine at the Interface of the Life and Physical Sciences (R01) Apply for PAR 10 141 Funding Number: PAR 10 141 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Centers of Excellence for Research on CAM (CERC) for Pain (P01) Apply for RFA AT 10 002 Funding Number: RFA AT 10 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Methods for Prevention Packages Program (MP3 II) (R01) Apply for RFA AI 10 005 Funding Number: RFA AI 10 005 Agency: National Institutes of Health Category: Health Funding Amount: $600,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS10 1087", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.